![Morten Graugaard Døssing](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Morten Graugaard Døssing
Directeur Général chez
Orbis Medicines ApS
Profil
Morten Graugaard Døssing holds the position of Chief Executive Officer at Orbis Medicines ApS starting in 2025.
He is a Director at Hoba Therapeutics ApS.
Since 2018, he has been a Non Executive Director at Precirix NV.
Since 2016, he has been a Principal at Novo Seeds.
Current jobs include Chief Executive Officer at Orbis Medicines ApS, Director at Hoba Therapeutics ApS, Non Executive Director at Precirix NV, and Principal at Novo Seeds.
Postes actifs de Morten Graugaard Døssing
| Sociétés | Poste | Début |
|---|---|---|
Novo Seeds
 Novo Seeds Investment ManagersFinance Novo Seeds invests in companies located in Europe and the United States. The fund targets companies operating in the fields of life science and healthcare technology sectors. It provides financing for seed and early stage capital requirement. | Private Equity Investor | 01/04/2016 |
Hoba Therapeutics ApS
 Hoba Therapeutics ApS BiotechnologyHealth Technology Engages in research and development of therapeutics for pain, hearing loss and sensory neuron disorders | Directeur/Membre du Conseil | - |
Precirix NV
 Precirix NV Pharmaceuticals: MajorHealth Technology Develops radiopharmaceuticals for cancer treatment | Directeur/Membre du Conseil | 01/11/2018 |
Orbis Medicines ApS
 Orbis Medicines ApS Internet Software/ServicesTechnology Services Operates as a novel macrocyclic chemistry and computational platform for drug discovery | Directeur Général | 06/01/2025 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
31
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Novo Seeds
Novo Seeds Investment ManagersFinance Novo Seeds invests in companies located in Europe and the United States. The fund targets companies operating in the fields of life science and healthcare technology sectors. It provides financing for seed and early stage capital requirement. | Finance |
Hoba Therapeutics ApS
Hoba Therapeutics ApS BiotechnologyHealth Technology Engages in research and development of therapeutics for pain, hearing loss and sensory neuron disorders | Health Technology |
Precirix NV
Precirix NV Pharmaceuticals: MajorHealth Technology Develops radiopharmaceuticals for cancer treatment | Health Technology |
Orbis Medicines ApS
Orbis Medicines ApS Internet Software/ServicesTechnology Services Operates as a novel macrocyclic chemistry and computational platform for drug discovery | Technology Services |
